Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia

被引:0
|
作者
Genc, A. [1 ]
Kalelioglu, T. [2 ]
Karamustafalioglu, N. [2 ]
Tasdemir, A. [3 ]
Genc, E. Sena [2 ]
Akkus, M. [2 ]
Emul, M. H. [4 ]
机构
[1] Sisli Etfal Educ & Res Hosp, Psychiat, Istanbul, Turkey
[2] Bakirkoy Res & Training State Hosp, Psychiat, Istanbul, Turkey
[3] Samsun Mental & Neurol Hlth Hosp, Psychiat, Samsun, Turkey
[4] Istanbul Univ, Psychiat, Cerrahpasa Med Sch, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.1.f.013
引用
收藏
页码:S232 / S233
页数:2
相关论文
共 50 条
  • [11] SERUM UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE PANCREATITIS
    Can, Ummugulsum
    Baser, Salih
    Yerlikaya, Fatma Humeyra
    Karasoy, Deniz
    NOBEL MEDICUS, 2021, 17 (01): : 48 - 53
  • [12] Soluble urokinase-type plasminogen activator receptor (suPAR) and interleukin-6 levels in hyperemesis gravidarum
    Desdicioglu, Raziye
    Yildirim, Melahat
    Kocaoglu, Gulcan
    Cendek, Busra Demir
    Avcioglu, Gamze
    Tas, Emre Erdem
    Sengul, Ozlem
    Erel, Ozcan
    Yavuz, Ayse Filiz
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (09) : 825 - 829
  • [13] Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
    Gumus, Aziz
    Altintas, Nejat
    Cinarka, Halit
    Kirbas, Aynur
    Haziroglu, Muge
    Karatas, Mevlut
    Sahin, Unal
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [14] Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD
    AboEl-Magd, Gehan Hassan
    Mabrouk, Maaly Mohamed
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2018, 44 (01) : 36 - 41
  • [15] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [16] Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis
    Georgescu, Anca-Meda
    Szederjesi, Janos
    Voidazan, Septimiu
    Dobreanu, Minodora
    Copotoiu, Sanda Maria
    Hutanu, Adina
    Azamfirei, Leonard
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (01): : 59 - 73
  • [17] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [18] Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD
    Gumus, Aziz
    Altintas, Nejat
    Cinarka, Halit
    Kirbas, Aynur
    Haziroglu, Muge
    Karatas, Mevlut
    Sahin, Unal
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 357 - 365
  • [19] Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with acute pancreatitis (AP) - Progress in prediction of AP severity
    Lipinski, Michal
    Rydzewska-Rosolowska, Alicja
    Rydzewski, Andrzej
    Cicha, Malgorzata
    Rydzewska, Grazyna
    PANCREATOLOGY, 2017, 17 (01) : 24 - 29
  • [20] Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor (suPAR) levels
    Isola, Gaetano
    Polizzi, Alessandro
    Alibrandi, Angela
    Williams, Ray C.
    Leonardi, Rosalia
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (06) : 896 - 906